NCT03935854View on ClinicalTrials.gov

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

August 11, 2022

Study Completion Date

August 11, 2022

Conditions
ObesityKetogenic DietingMetabolic SyndromeBipolar DisorderSchizophreniaWeight GainPsychotropic Agents Causing Adverse Effects in Therapeutic UseBrain Metabolic Disorder
Interventions
OTHER

LCHF, Ketogenic Diet

Low Carbohydrate, Moderate Protein, High Fat Ketogenic Dietary Intervention 16 weeks

Trial Locations (1)

94305

Stanford University Department of Psychiatry & Behavioral Sciences, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03935854 - Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness | Biotech Hunter | Biotech Hunter